At Forever Young, we offer GLP-1 injections, including Semaglutide and Tirzepatide, specifically for weight management and loss
Currently, there is no FDA-approved indication for GLP-1 receptor agonists in the treatment of Crohn's disease or any form of IBD
The bigger safety concern is opportunity cost
CrossRef Synergistic anti-obesity effects of Bifidobacterium breve BR3 and Lactiplantibacillus plantarum LP3 via coordinated regulation of lipid metabolism and gut microbiota Misun Yun, Dooheon Son, Namhee Kim, Se Hee Lee, Eunbee Cho, Sanghyun Lim Journal of Microbiology.2025
At Our Company, we believe that informed research, supported by professional medical advice, is the foundation for a successful experience
Smith TJ